FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1767400858> ?p ?o ?g. }

• W1767400858 endingPage "1735" @default.
• W1767400858 startingPage "1723" @default.
• W1767400858 abstract "We have previously demonstrated an association between combination antiretroviral therapy and the risk of myocardial infarction. It is not clear whether this association differs according to the class of antiretroviral drugs. We conducted a study to investigate the association of cumulative exposure to protease inhibitors and nonnucleoside reverse-transcriptase inhibitors with the risk of myocardial infarction.We analyzed data collected through February 2005 from our prospective observational study of 23,437 patients infected with the human immunodeficiency virus. The incidence rates of myocardial infarction during the follow-up period were calculated, and the associations between myocardial infarction and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors were determined.Three hundred forty-five patients had a myocardial infarction during 94,469 person-years of observation. The incidence of myocardial infarction increased from 1.53 per 1000 person-years in those not exposed to protease inhibitors to 6.01 per 1000 person-years in those exposed to protease inhibitors for more than 6 years. After adjustment for exposure to the other drug class and established cardiovascular risk factors (excluding lipid levels), the relative rate of myocardial infarction per year of protease-inhibitor exposure was 1.16 (95% confidence interval [CI], 1.10 to 1.23), whereas the relative rate per year of exposure to nonnucleoside reverse-transcriptase inhibitors was 1.05 (95% CI, 0.98 to 1.13). Adjustment for serum lipid levels further reduced the effect of exposure to each drug class to 1.10 (95% CI, 1.04 to 1.18) and 1.00 (95% CI, 0.93 to 1.09), respectively.Increased exposure to protease inhibitors is associated with an increased risk of myocardial infarction, which is partly explained by dyslipidemia. We found no evidence of such an association for nonnucleoside reverse-transcriptase inhibitors; however, the number of person-years of observation for exposure to this class of drug was less than that for exposure to protease inhibitors." @default.
• W1767400858 created "2016-06-24" @default.
• W1767400858 creator A5001375239 @default.
• W1767400858 creator A5004174170 @default.
• W1767400858 creator A5010009356 @default.
• W1767400858 creator A5027160828 @default.
• W1767400858 creator A5028610566 @default.
• W1767400858 creator A5037870737 @default.
• W1767400858 creator A5037887037 @default.
• W1767400858 creator A5078674653 @default.
• W1767400858 creator A5078701955 @default.
• W1767400858 creator A5079993549 @default.
• W1767400858 creator A5081694461 @default.
• W1767400858 creator A5088502098 @default.
• W1767400858 date "2007-04-26" @default.
• W1767400858 modified "2023-10-06" @default.
• W1767400858 title "Class of Antiretroviral Drugs and the Risk of Myocardial Infarction" @default.
• W1767400858 cites W1497170016 @default.
• W1767400858 cites W1690495699 @default.
• W1767400858 cites W1979625649 @default.
• W1767400858 cites W1984904918 @default.
• W1767400858 cites W1985646480 @default.
• W1767400858 cites W1997841312 @default.
• W1767400858 cites W2007742356 @default.
• W1767400858 cites W2013779079 @default.
• W1767400858 cites W2027953606 @default.
• W1767400858 cites W2031498851 @default.
• W1767400858 cites W2060825301 @default.
• W1767400858 cites W2073738273 @default.
• W1767400858 cites W2088828424 @default.
• W1767400858 cites W2099509337 @default.
• W1767400858 cites W2104937096 @default.
• W1767400858 cites W2119843180 @default.
• W1767400858 cites W2136097824 @default.
• W1767400858 cites W2153335144 @default.
• W1767400858 cites W2155449170 @default.
• W1767400858 cites W2156188065 @default.
• W1767400858 cites W2157138119 @default.
• W1767400858 cites W2159584933 @default.
• W1767400858 cites W2318289184 @default.
• W1767400858 cites W2321852728 @default.
• W1767400858 cites W4234806062 @default.
• W1767400858 cites W4296391115 @default.
• W1767400858 doi "https://doi.org/10.1056/nejmoa062744" @default.
• W1767400858 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17460226" @default.
• W1767400858 hasPublicationYear "2007" @default.
• W1767400858 type Work @default.
• W1767400858 sameAs 1767400858 @default.
• W1767400858 citedByCount "1383" @default.
• W1767400858 countsByYear W17674008582012 @default.
• W1767400858 countsByYear W17674008582013 @default.
• W1767400858 countsByYear W17674008582014 @default.
• W1767400858 countsByYear W17674008582015 @default.
• W1767400858 countsByYear W17674008582016 @default.
• W1767400858 countsByYear W17674008582017 @default.
• W1767400858 countsByYear W17674008582018 @default.
• W1767400858 countsByYear W17674008582019 @default.
• W1767400858 countsByYear W17674008582020 @default.
• W1767400858 countsByYear W17674008582021 @default.
• W1767400858 countsByYear W17674008582022 @default.
• W1767400858 countsByYear W17674008582023 @default.
• W1767400858 crossrefType "journal-article" @default.
• W1767400858 hasAuthorship W1767400858A5001375239 @default.
• W1767400858 hasAuthorship W1767400858A5004174170 @default.
• W1767400858 hasAuthorship W1767400858A5010009356 @default.
• W1767400858 hasAuthorship W1767400858A5027160828 @default.
• W1767400858 hasAuthorship W1767400858A5028610566 @default.
• W1767400858 hasAuthorship W1767400858A5037870737 @default.
• W1767400858 hasAuthorship W1767400858A5037887037 @default.
• W1767400858 hasAuthorship W1767400858A5078674653 @default.
• W1767400858 hasAuthorship W1767400858A5078701955 @default.
• W1767400858 hasAuthorship W1767400858A5079993549 @default.
• W1767400858 hasAuthorship W1767400858A5081694461 @default.
• W1767400858 hasAuthorship W1767400858A5088502098 @default.
• W1767400858 hasBestOaLocation W17674008581 @default.
• W1767400858 hasConcept C120665830 @default.
• W1767400858 hasConcept C121332964 @default.
• W1767400858 hasConcept C126322002 @default.
• W1767400858 hasConcept C142462285 @default.
• W1767400858 hasConcept C164705383 @default.
• W1767400858 hasConcept C181199279 @default.
• W1767400858 hasConcept C188816634 @default.
• W1767400858 hasConcept C203014093 @default.
• W1767400858 hasConcept C2776714187 @default.
• W1767400858 hasConcept C2777351918 @default.
• W1767400858 hasConcept C2777798775 @default.
• W1767400858 hasConcept C2993143319 @default.
• W1767400858 hasConcept C3013748606 @default.
• W1767400858 hasConcept C44249647 @default.
• W1767400858 hasConcept C500558357 @default.
• W1767400858 hasConcept C55493867 @default.
• W1767400858 hasConcept C61511704 @default.
• W1767400858 hasConcept C71924100 @default.
• W1767400858 hasConcept C82789193 @default.
• W1767400858 hasConcept C86803240 @default.
• W1767400858 hasConceptScore W1767400858C120665830 @default.
• W1767400858 hasConceptScore W1767400858C121332964 @default.
• W1767400858 hasConceptScore W1767400858C126322002 @default.

• next